Datopotamab deruxtecan Antibody

SKU: orb1984608

Description

Datopotamab deruxtecan is a TROP2-directed antibody-drug conjugate (ADC) demonstrating potent antitumor activity. It exhibits antibody-dependent cellular cytotoxicity in vitro and effectively suppresses tumor growth in xenograft models, supporting its research in oncology for both in vitro and in vivo experimental applications.

Research Area

Immunology & Inflammation, Molecular Biology

Key Properties

• Antibody Type: Inhibitor Antibody
• Target: Antibody-Drug Conjugates (ADCs),Topoisomerase,TROP2
• Molecular Weight: 145.16 kDa
• Purity: 95.64% (May vary between batches)
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Concentration: 9.61 mg/mL
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates (ADCs), Antibody-Drug Conjugates, AntibodyDrugConjugates(ADCs), AntibodyDrugConjugates, ADCs, Dato-DXd, Datopotamab deruxtecan, DS1062, DS-1062, DS 1062, S-1062a, Topoisomerase

Quick Database Links

Gene Symbol

Antibody-Drug Conjugates (ADCs),Topoisomerase,TROP2